Lucence (@LucenceHealth) header
Lucence (@LucenceHealth) profile picture

Earlier Detection. Better Health.

Palo Alto, California
Joined August 2016
Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)Photo by Lucence (@LucenceHealth)
Besides the regular @ASCO #ASCO23 program, there are a number of interesting sponsored presentations. Join me for dinner & discussion about #ctRNA being a game changer for #lungcancer detection and treatment selection #liquidbiopsy. June 3 - 6:30pm CT, hosted by @lucencehealth bit.ly/lucence-asco23-dinner @SylvesterCancer @ChristianRolfo @JackWestMD @n8pennell @NarjustFlorezMD @SamuelKareffMD @PriscilaBCMD @Latinamd @MudadRaja
1
7
73
7,678
Replying to @YawBediako_
@YawBediako_ Founder and CEO Yemaachi and among @NewAfricanMag's 100 Most Influential Africans, is on a mission to fix unequal healthcare for patients with African ancestry. Such a moment for this genomics partnership born out of our work together at @VAInstitute !
3
1
6
2,594
proud to be on the scientific board for @LucenceHealth - we have three posters on our liquid biopsy platform @asco #asco22 @minhantan
2
1
14
Thank you, @LucenceHealth, for supporting Conquer Cancer! Make sure to visit #ASCO22 booth 16112 where health care practitioners can choose a charity to a receive a $50 donation from Lucence when they provide their email address.
1
1
Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA. The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform. ow.ly/Tztv103FzBl
Collaboration with @LucenceHealth to evaluate a sensitive ctDNA platform-co-led by Dr Praful Ravi @DanaFarber_GU- BRCA and PIK3CA mutations may be candidates for resistance to #immune checkpoint inhibitors in metastatic #urothelialcarcinoma
#ESMO21: Dana-Farber's Guru Sonpavde, MD (@sonpavde), details a study looking at circulating tumor DNA alterations to identify resistance mechanisms to immune checkpoint inhibitors in metastatic urothelial #carcinoma 👉 Abstract 709P: ms.spr.ly/6015XpYqL cc @DanaFarber_GU
6
1
13
Exciting collaboration of @DanaFarber_GU with @LucenceHealth-presentation #ESMO2021-sensitive ctDNA platform sheds insights on #bladdercancer biology-PI3K and BRCA alterations appear to be resistance mechanisms in selected metastatic patients on #immune checkpoint inhibitors
Lucence at #ESMO2021 Lucence is delighted to present new data from a study in collaboration with @DanaFarber showing the utility of liquid biopsy in late-stage bladder cancer. Read our press release bwnews.pr/2XevFWi Read our abstract https://nitter.gq/t.co/HjVch6veX1
8
15
With CLIA licensing of our Palo Alto laboratory, Lucence can now offer US cancer patients our ultrasensitive liquid biopsy test LiquidHALLMARK with much faster turnaround times. Read more here: bwnews.pr/3m3euxe
Toward a SAFER World - SAFER Technology suite for COVID-19 mass-testing ✅Solve unlinked cases in days not weeks for community control - DeepMark™
2
3
Toward a SAFER World - SAFER technology suite for COVID-19 mass-testing ✅Detect 36% more COVID-19 infections with saliva over swabs - SAFER™ ✅Reduce vibration-arm syndrome and hands-on time for saliva processing by 83% - Starlight™ youtu.be/1cvAqEC6V5o
1
2
On 5 August, tune in to an informative webinar hosted by @LucenceDx, our #MedTech portfolio company, as they give a comprehensive overview of the current testing landscape, plus key innovations to ramp up worldwide #COVID19 testing capacity. https://nitter.gq/t.co/yhzdpEROmm

1
3
Thank you #SingaporeSocietyofOncology @LucenceDx Tan Min Han, Rajesh Shah and Toh Chee Keong for a great discussion on #COVID19nCancer #LCSM #CCC19 @COVID19nCCC
Join @COVID19nCCC member @GlopesMd & a panel of experts for a conversation on #COVID19 & #lungcancer tomorrow at 8 PM ET/5 PM PT, hosted by the Singapore Society of Oncology. Register here: https://nitter.gq/t.co/XunRg67r0V #LCSM
1
1
6
Very happy to see friends and colleagues from Asia and around the world joining us for this event. #Covid19nCancer #ccc19 @COVID19nCCC – at Miami, FL
Join @COVID19nCCC member @GlopesMd & a panel of experts for a conversation on #COVID19 & #lungcancer tomorrow at 8 PM ET/5 PM PT, hosted by the Singapore Society of Oncology. Register here: https://nitter.gq/t.co/XunRg67r0V #LCSM
4
9
34
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials [Jun 1, 2020] @junger47 et al. @JAMANetworkOpen ow.ly/hIo030qLGjq #COVID19ClinicalTrials #CCC19 #COVID19nCancer #2019nCoV #COVID19 @COVID19nCCC
8
1
Lucence retweeted
In the near term, the Singapore-based firm will focus on launching a laboratory-developed test version of its LiquidHallmark late-stage lung cancer treatment selection assay @LucenceDx #cancer https://nitter.gq/t.co/OVxOQyvk70
2
2
Our study is out! #CCC19 @asco #asco20 #covid19ncancer @oncoalert @totalhealthconf @sylvestercancer is proud to be one of the five founding institutions - A big thank you to all participants. This was a grassroots, crowdsourcing effort nobody could do alone @thelancet
1
32
6
97
#ASCO20 Tip: It's a good idea to log in today or tomorrow to make sure you can log in successfully to the @ASCO website, and see the Virtual Program. #ASCO20 begins Friday May 29, 8 am Eastern Time (rise and shine, those of you on the West Coast). meetings.asco.org/am/virtual…
We need to learn/borrow/emulate everything we can from the countries that are winning on the fight against #COVID19. There are some gems in here from @hsuliyang and @minhantan on how Singapore has been responding. statnews.com/2020/03/23/sing…